Knight Therapeutics | GUD - 净收入

金融业

CAD

CAD 1.05B

现金及等价物

CAD 76.45M

CAD 82.22M

CAD 394.84M

CAD 165.26M

CAD 77.91M

CAD 6.21M

CAD 24.45M

698

EPS每股收益

CAD 0.13

股本和储备

CAD 767.27M

CAD 64.72M

债务利息支出

CAD 3.92M

CAD 2.46M

CAD 57.78M

CAD 955.05M

CAD -3.79M

CAD 126.9M

CAD 6.21M

普通股股本

CAD 99.68M

257.34

CAD -1.92M

CAD 133.11M

销售和管理费用

CAD 35.45M

CAD 95.4M

贸易债权人

CAD 125.76M

应收帐款人

CAD 183M

	净收入	更改		日
Acasti Pharma	USD -938K		2.42M	2025-09
Akebia Therapeutics	USD -12.24M		12.78M	2025-12
Alaunos Therapeutics	USD -1.01M		153K	2026-03
Aurora Cannabis	CAD 1.82M		53.29M	2025-12
Avita Medical	AUD -11.62M		1.7M	2025-12
Canopy Growth	CAD -62.63M		60.99M	2025-12
Cronos Group	USD 13.75M		15.57M	2026-03
Dianthus Therapeutics	USD -64.43M		27.67M	2025-12
Ionis Pharmaceuticals	USD -93M		136M	2026-03
IQVIA Holdings	USD 274M		240M	2026-03
Knight Therapeutics	CAD -3.79M		8.83M	2025-09
Moderna	USD -1.34B		517M	2026-03
Omeros	USD -32.23M		23.81M	2024-09
Organigram Holdings	CAD 19.97M		57.93M	2025-12
Organon & Co	USD -205M		365M	2025-12
Revvity	USD 40.72M		57.65M	2026-03
Tectonic Therapeutic	USD -19.23M		186K	2025-12
Tilray	USD -44.93M		44.61M	2025-09
Viatris	USD 176.4M		516.5M	2026-03
Xeris Pharmaceuticals	USD 11.08M		10.46M	2025-12